Materials and methods: From the stem bark of Turraea robusta six compounds, and from various parts of Turraea nilotica eleven compounds were isolated by the use of a combination of chromatographic techniques. The structures of the isolated compounds were elucidated using NMR and MS, whilst the relative configuration of one of the isolated compounds, toonapubesin F, was established by X-ray crystallography. The antiplasmodial activities of the crude extracts and the isolated constituents against the D6 and W2 strains of Plasmodium falciparum were determined using the semiautomated micro dilution technique that measures the ability of the extracts to inhibit the incorporation of (G-3 H, where G is guanine)
hypoxanthine into the malaria parasite. The cytotoxicity of the crude extracts and their isolated constituents was evaluated against the mammalian cell lines African monkey kidney (vero), mouse breast cancer (4T1) and human larynx carcinoma (HEp2).
Results: The extracts showed good to moderate antiplasmodial activities, where the extract of the stem bark of T. robusta was also cytotoxic against the 4T1 and the HEp2 cells (IC 50 < 10 μg/ml). The compounds isolated from these extracts were characterized as limonoids, protolimonoids and phytosterol glucosides. These compounds showed good to moderate activities with the most active one being azadironolide, IC 50 2.4 ± 0.03 μM and 1.1 ± 0.01 μM against the D6 and W2 strains of Plasmodium falciparum, respectively; all other compounds possessed IC 50 14.4 -40.5 μM. None of the compounds showed significant cytotoxicity against vero cells, yet four of them were toxic against the 4T1 and HEp2 cancer cell lines with piscidinol A having IC 50 8.0 ± 0.03 and 8.4 ±0.01 μM against the 4T1 and HEp2 cells, respectively. Diacetylation of piscidinol A resulted in reduced cytotoxicity.
Conclusion: From the medicinal plants Turraea robusta and Turraea nilotica, twelve compounds were isolated and characterized; two of the isolated compounds, namely 11-epi-Introduction
The genus Turraea (family Meliaceae) consists of circa 70 species, mainly shrubs and small trees, and is widely distributed in Eastern Africa. Several of its species are used in indigenous medicine for the treatment of gastrointestinal disorders (Kokwaro, 2009) . For example T.
floribunda is used as an emetic and purgative, T. holstii is used to treat diarrhoea and constipation, and T. mombassana against excess bile, malaria and other fevers. T. robusta is utilized to treat malaria, stomach pain, diarrhoea and gastrointestinal discomfort (Gathirwa et al., 2008; Kokwaro, 2009) . Its leaves are used as an antidote for poisoning. The roots of Turraea nilotica are also used for the treatment of stomach disorders in traditional medicine (Kokwaro, 2009 ).
The methanolic root bark extract of T. robusta was previously reported to possess antiplasmodial and antimalarial activities, with negligible toxicity (mice oral LD 50 > 5000 mg/kg body weight) (Irungu et al., 2007; Gathirwa et al., 2008) . Previous phytochemical investigations of the root bark of T. robusta led to the isolation of triterpenoids which included five limonoids (Rajab et al., 1988; Bentley et al., 1992) . There are no phytochemical and antiplasmodial reports on the stem bark of T. robusta. The root and stem bark of T.
nilotica led to the identification of a limonoid and three protolimonoids (Mulholland and Taylor, 1988; Bentley et al., 1995) . These compounds were not evaluated for their antiplasmodial and cytotoxic properties. In our search for plant secondary metabolites with potential cytotoxic and/or antiplasmodial activities, the crude extracts and the isolated secondary metabolites of T. nilotica Kotschy and Peyr, and of T. robusta Gürke were tested against chloroquine resistant (W2) and chloroquine sensitive (D6) strains of Plasmodium falciparum. In addition, their cytotoxicity against three mammalian cell lines, African green monkey kidney (vero), mouse breast cancer (4T1) and human larynx carcinoma (HEp2) was evaluated. Here, the isolation and the characterization of the constituents of the crude extracts as well as their antiplasmodial and cytotoxic activities are reported.
Materials and Methods
The University of Nairobi where voucher specimens were deposited.
Antiplasmodial assay
Continuous in vitro cultures of asexual erythrocytic stages of P. falciparum strains (W2 and D6) were maintained following previously described procedures (Kigondu et al., 2009) . A drug assay was carried out following a modification of the semiautomated micro dilution technique that measures the ability of the extracts to inhibit the incorporation of (G-3H)
hypoxanthine into the malaria parasite (Gathirwa et al., 2008) . Plates were harvested onto glass fibre filters and hypoxanthine (G-3H) uptake determined using a micro-beta trilux Results were expressed as the drug concentration required for 50% inhibition of (G-3H)
hypoxanthine incorporation into parasite nucleic acid, using a non-linear regression analysis of the dose-response curve. The criterion for scoring activity of compounds described by Batista et al., (2009) was adopted: IC 50 < 1 μM, highly active; IC 50 ≥ 1 and <20 μM, active; IC 50 ≥ 20-100 μM, moderate activity; IC 50 > 100 inactive.
Cytotoxicity assay
Rapid colorimetric assay was carried out using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-zolium bromide (MTT) (Mosmann, 1983 ). This assay is based on the ability of a mitochondrial dehydrogenase enzyme of viable cells to cleave the tetrazolium rings of the pale yellow MTT and thereby form dark blue formazan crystals, which are largely impermeable to cell membranes, resulting in their accumulation within healthy cells. The amount of generated formazan is directly proportional to the number of cells (Mosmann, 1983) . In this assay, the mammalian cell lines African monkey kidney (vero), mouse breast cancer (4T1) and human larynx carcinoma (HEp2) were used. Cells were maintained in Eagle's Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS). A cell density of 20 000 cells per well in 100 μL serum were seeded on 96-well plates and incubated for 12 hours at 37 °C and 5% CO 2 to attach to the surface. Following 12 hours, the medium was replaced with maintenance medium containing the appropriate drug concentration, 0.14 to 100 μg/mL, or vehicle control (≤ 1.0% v/v DMSO). After an incubation of 48 hours, cell viability was measured by addition of 10 µL of MTT reagent (5 mg MTT in 1ml of PBS). The plates were incubated for an additional 4 hours at the same conditions. Next, all media was removed from the plates and 100 µL DMSO was added to dissolve the formazan crystals. The plates were read on a Multiskan EX Labsystems scanning multi-well spectrophotometer at 562 nm, and 620 nm as reference. The results were recorded as optical density (OD) per well at each drug concentration, the data was transferred into the software Microsoft Excel 2007 and expressed as percentage of the untreated controls.
Percentage cytotoxicity (PC) as compared to the untreated controls was calculated using the following equation:
where A is the mean OD of the untreated cells and B is the mean OD at each drug concentration. The drug concentration required for 50% inhibition of cell growth, using nonlinear regression analysis of the dose-response curve, was calculated. Cytotoxicity was defined as toxic if IC 50 < 100 ug/ml.
Extraction and Isolation

Turraea robusta
The air dried and ground stem bark of T. robusta (1.4 kg) was extracted with MeOH/CH 2 Cl 2
(1:1) at room temperature (2 x 3 L, 48 h each). The filtrate was dried in vacuo using a rotary evaporator to yield dark red oil (144 g). A 79 g portion of the extract was fractionated using yield 12α-acetoxy-7-deacetylazadirone (2, 7.0 mg) and mzikonone (3, 6.3 mg). Fraction TR8 (3.0 g) was re-chromatographed on silica gel column (30 g, 2 cm × 30 cm) eluting with petroleum ether/ethyl acetate (9:1) and a subfraction containing one major compound was purified on PTLC, eluting with petroleum ether/acetone (7:4) to yield azadironolide (5, 16.5 mg). Fractions TR9-10 were combined (145.2 mg) and were separated on PTLC eluting with petroleum ether/chloroform/methanol (10:2:1) yielding 11-epi-toonacilin (4, 3.0 mg). The purification of fraction TR11 (331.9 mg) on PTLC using petroleum ether/chloroform/methanol (12:2:1) eluent gave turranolide (6, 17.7 mg).
Turraea nilotica
The air dried and grounded stem bark of T. nilotica (1.2 kg) was extracted and dried following the procedure described in section 2.3.1. to yield a dark gum (59 g). A 58 g portion of the extract was fractionated by silica gel column chromatography (400 g, 5 cm × 30 cm) using petroleum ether (40-60 °C) and increasing proportions of ethyl acetate as eluent. A total of 50 fractions, ca. 250 mL each, were collected and combined into 20 major fractions, labelled TN1-20, upon TLC analyses. Repeated silica gel column chromatography (10 g, 2 cm × 30 cm) of fraction TN12 (1.35 g) eluting with 9:1 petroleum ether/acetone yielded niloticin (8, 9.3 mg). Fractions TN13-15 (7g) were combined and purified by silica gel column chromatography (100 g, 2 × 30 cm) using petroleum ether and increasing portions of acetone; crystallization of the residue from an acetone/dichloromethane mixture yielded toonapubesin F (11, 20.1 mg). A repeated column chromatographic (30 g, 2 cm × 30 cm) separation of fraction TN16 (3 g) in silica gel followed by crystallization from a methanol/dichloromethane mixture yielded piscidinol A (10, 775.6 mg). Fraction TN18 was crystallized from methanol/dichloromethane (1:9) to yield hispidol B (9, 84.2 mg).
The root bark of Turraea nilotica (837 g) was extracted and dried as described in section 2.3.1 above yielding 13 g of a yellowish gum. A portion of the extract (11 g) was fractionated by silica gel column chromatography (88 g, 2 cm × 30 cm) using a petroleum ether:acetone gradient, with increasing polarity. Forty six fractions, ca. 100 mL each, were collected and combined into 20 major fractions, labelled TN21-40, based on their TLC profile. Fraction TN27 (140.7 mg) was purified on PTLC eluting with petroleum ether/acetone (9:1) to yield azadirone (1, 8.3 mg). Fraction TN32 (366 mg) was subjected to RP-HPLC (CH 3 OH/water) yielding 12α-acetoxy-7-deacetylazadirone (2, 18.5 mg) and mzikonone (3, 4.4 mg). Repeated column chromatographic purification of fraction TN36 (358 mg) followed by PTLC with a petroleum ether/chloroform/methanol (10:2:1) mixture as eluent yielded 1α,3α-diacetyl-7α-tigloyvilasinin (7, 11.6 mg).
The dried and grounded leaves of T. nilotica (500 g) were extracted as described in section 
Structure Elucidation
For structure elucidation 1 H, 13 C, gCOSY, gNOESY, gHSQC and gHMBC NMR spectra were acquired on an Bruker Avance III HD 800 MHz, on a Varian VNMR-S 500 or a Varian 400 MR spectrometer. The spectra were processed using the MestReNova (v9.0.0) software.
Chemical shifts were referenced indirectly to tetramethylsilane via the residual solvent signal ( 
X-ray diffraction
Crystals of compound 11 was selected and mounted under a stereo microscope on to a glass fibre and transferred to a Rigaku R-AXIS IIc image plate system. Diffracted intensities were measured using graphite-monochromated Mo Kα (λ = 0.710 73 Å) radiation from a RU-H3R
rotating anode operated at 50 kV and 40 mA. Using the R-AXIS IIc detector, 90 oscillation photos with a rotation angle of 2° were collected and processed using the CrystalClear software package. An empirical absorption correction was applied using the REQAB program under CrystalClear. All structures were solved by direct methods (SIR 97) (Altomare et al., 1999) and refined using full-matrix least-squares calculations on F2
(SHELXL-97) (Sheldrick, 2007) operating in the WinGX program package. Anisotropic thermal displacement parameters were refined for all the non-hydrogen atoms. Hydrogen atoms were included in calculated positions and refined using a riding model. Displacement ellipsoids are drawn with ORTEP-3 for Windows under WinGX.
Acetylation
A 20 mg portion of compound 8 or 10 was dissolved in 1 mL pyridine and then 1 mL acetic anhydride was added. The mixture was stirred overnight, and subsequently methanol was added and the solvent was removed under vacuum. The acetate precipitated by addition of water while stirring briskly, and it was filtered and dried. The procedure yielded niloticin acetate (17, 5 mg) and piscidinol A diacetate (18, 7 mg), respectively.
Results and Discussion
Antiplasmodial and cytotoxic activities
The crude extracts of T. nilotica and T. robusta were evaluated for antiplasmodial activity against the chloroquine-resistant (W2) and chloroquine-sensitive (D6) Plasmodium falciparum strains (Table 1) . The stem bark of T. robusta showed high antiplasmodial activity with IC 50 2.8 ± 0.02 μg/mL and 2.3 ± 0.05 μg/mL against the W2 and D6 strains, respectively. The stem and root barks of T. nilotica also displayed considerable antiplasmodial activities (IC 50 < 10 μg/ml) while its leaves showed only moderate activity.
Cytotoxicity of these extracts was evaluated against three mammalian cell lines, namely
African green monkey kidney (vero), mouse breast cancer (4T1) and human larynx carcinoma (HEp2) ( Table 1 ). The stem bark extract of T. robusta was cytotoxic against the 4T1 and the HEp2 cells (IC 50 < 10 μg/ml), whereas the extract of T. nilotica possessed moderate cytotoxicity against the three cell lines studied. Notably, all the extracts had low selectivity index (< 10), defined as the ratio of IC 50 vero cells to IC 50 P. falciparum (D6). This may indicate that the good to moderate antiplasmodial activity observed for the above extracts may be due to their general cytotoxicity. The fractions obtained from the crude extracts were evaluated for their cytotoxicity against vero cells. Generally, they had lower cytotoxicity than the crude extracts. Except for fraction TN12 (IC 50 = 4.34 ± 0.04 μg/mL), most fractions showed moderate cytotoxicity. From the stem bark of Turraea robusta Guerke six known compounds were isolated: three ring A-D-intact limonoids, namely azadirone (1), 12α-acetoxy-7-deacetylazadirone (2) and mzikonone (3), and the ring B seco limonoid 11-epi-toonacilin (4) (Figure 1 ). In addition, it gave two other triterpenoids azadironolide (5) and turranolide (6). Compound 5 was isolated as an epimeric mixture, indicated by doubling of some of its NMR signals. Epimeric mixtures of limonoids having a hemiacetal functionality in place of a furan ring were previously reported (Cheplogoi and Mulholland, 2003; McFarland et al., 2004) . The secondary metabolite content of T. robusta stem bark was similar to those reported for other Turraea species, which have limonoids as the main constituents. Compounds 2 and 4 were reported from this species for the first time. This is the first report on the occurrence of compound 5 in the genus Turraea. Figure 1 , the limonoid 1α,3α-diacety-7α-tigloyvilasinin (7), the protolimonoids niloticin (8), hispidol B (9), piscidinol A (10) and toonapubesin F (11), the phytosterols sitosterol-3-O-β-D-glucopyranoside acetate (12), stigmasterol-3-O-β-D-glucopyranoside acetate (13), and sitosterol-3-O-β-D-glucopyranoside (14) were isolated from the root and stem barks of Turraea nilotica.
The structure of toonapubesin F (11), first isolated from Toona ciliate var. pubesins (Wang et al., 2011) , was further confirmed by an X-ray crystallographic analysis (Figure 4 ) from a single crystal obtained by slow crystallization from a mixture of dichloromethane and acetone. The atomic coordinates are given in the Supplementary Information. Figure 3 . ORTEP picture of toonapubesin F (11). All nonpolar hydrogens have been omitted for clarity. Displacement ellipsoids are drawn at the 50% probability level.
As the stereochemistry of the toonapubesin backbone is known (Wang, 2011) , the chirogenic centre at C4 is (S). Hence, this data allows identification of the oxidized methyl functionality on C4, i.e. C25 and not C24.
The roots, stem and leaves of Turraea nilotica, were found to contain different secondary metabolites. Limonoids were isolated from the root bark, and protolimonoids from the stem bark while phytosterols were isolated from the leaves. Limonoids, protolimnoids and steroids share a tetracyclic triterpenoid skeleton; however, they differ in the oxidation state of their side chain. Based on the previously proposed biosynthetic pathway of limonoids, (Champagne et al., 1992; Tan and Luo, 2011) T. nilotica is likely to follow the phytosterol (leaves) → protolimonoid (stem bark) → limonoid (root bark) biosynthetic pathway.
The antiplasmodial potency of some limonoids and other triterpenoids has been previously reported (Maneerat et al., 2008; Mohamad et al., 2009) . Therefore, some of the compounds isolated in this work were tested for antiplasmodial activities against the D6 and W2 Plasmodium falciparum strains (Table 2) . Their activity was scored according to the classification of Batista et al., (2009) , where IC 50 < 1 μM is highly active; 1 ≤ IC 50 ≤ 20 μM is active, 20 μM ≤ IC 50 ≤ 100 μM is moderately active, and IC 50 > 100 is inactive. Of the eight compounds tested, two showed good activity with the most active substance being the epimeric mixture azadironolide (5) (IC 50 < 2.4 μM), and six showed moderate activities against the W2 and D6 strains ( Table 2 ). The antiplasmodial activity of compound 1 is in agreement with the previous literature data (Chianese et al., 2010) .
The isolated compounds were also tested for cytotoxicity (Table 2) Thus, the observed moderate antiplasmodial activity of these compounds is likely due to general cytotoxicity, rather than due to a specific activity against the Plasmodium parasite. It should, however, be noted that compounds 4 and 5 that are classified as active, were observed to have comparably high selectivity index SI > 10.5 and 11.5, respectively, though significantly lower than chloroquine (SI = 5702).
Although the investigated plants are in traditional medicinal use against malaria, and their crude extracts showed promising antimalarial activities, their isolated metabolites did not display considerable activity against P. falciparum. This may be explained by synergetic effects or by the loss of one or some minor yet highly active metabolites during the purification process. For an improved understanding of the traditional medicinal applicability of these plants further studies are necessary.
Some limonoids and protolimonoids isolated from other plants were previously reported to possess substantial cytotoxicity (Maneerat et al., 2008) , which, along with the high to moderate cytotoxicity of the crude extracts and isolated compounds against 'normal' vero cells motivated the evaluation of cytotoxicity of the isolated constituents against the cancerous cell lines 4T1 and HEp2 (Table 2) . Compounds 1, 5, 8-10 showed high cytotoxicities against the 4T1 and HEp2 cell lines with IC 50 < 20 µM. It should be stressed that these compounds showed moderate cytotoxicity against 'normal' vero cells, yet high cytotoxicity against cancerous cell lines. Hence these compounds may be promising leads for development of anticancer agents (Diantini et al., 2012) .
For assessment of the importance of the free hydroxyl groups of compound 8 and 10 on their bioactivities, they were acetylated to give niloticin acetate (17) and piscidinol A diacetate 
The chemotaxonomic significance of Turraea limonoids
Various classes of limonoids were reported from the genus Turraea with each species synthesizing more than one class of limonoids. Ring intact limonoids were reported from eight Turraea species, namely T. robusta, T. nilotica, T. cornucopia, T. parvifolia, T. floribunda, T. holstii, T. wakefieldii and T. pubescens (Bentley et al., 1992; Ndung'u et al., 2004; Owino et al., 2008; Yuan et al., 2013) . So far, ring A seco limonoids have only been isolated from T. wakefieldii (Ndung'u et al., 2003) , whereas ring B seco limonoids were reported in T. floribunda, T. holstii and T. pubescens (Mulholland et al., 1998; McFarland et al., 2004; Yuan et al., 2013) . Ring A-B seco limonoids were reported from T. mombassana and T. obtusifolia, while ring C seco limonoids from T. holstii and T. pubescens (Adul et al., 1993; Sarker et al., 1997; Mulholland et al., 1998; Yuan et al., 2013) (Zhou et al., 1997) , the limonoids disclosed here have not been reported from any other genus. The occurrence of five limonoids in Turraea species is shown in Table 3 , among which 3 was isolated from five species. (2) T. robusta T. cornucopia T. pubescens --Mzikonone (3) T. robusta T. cornucopia T. parvifolia T. nilotica T. pubescens 11-epi-toonacilin (4) T. robusta T. holstii T. pubescens T. cornucopia -1α,3α-diacety-7α-tigloyvilasinin (7) T. nilotica T. parvifolia ---
Conclusion
Six compounds were isolated from the stem bark of Turraea robusta. Four of them were limonoids and two of them triterpenoids. Of these six compounds, azadironolide (5) is new to the genus. The secondary metabolites present in the stem bark were also found in the root bark. Compound 3 is a common limonoid in the genus Turraea, and was previously reported from five Turraea species (Cheplogoi and Mulholland, 2003; Owino et al., 2008; Yuan et al., 2013) . From the leaves, root and stem bark of Turraea nilotica twelve compounds were 
